4//SEC Filing
FEDERICO CHARLES 4
Accession 0001209191-13-014352
CIK 0001138400other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:48 PM ET
Size
27.3 KB
Accession
0001209191-13-014352
Insider Transaction Report
Form 4
FEDERICO CHARLES
Director
Transactions
- Tax Payment
Common Stock
2013-03-01$9.07/sh−11,977$108,677→ 7,834 total - Exercise/Conversion
Common Stock
2013-03-01$2.63/sh+20,000$52,600→ 27,834 total - Exercise/Conversion
Stock Options (right to buy)
2013-03-01−20,000→ 0 totalExercise: $2.63Exp: 2022-06-11→ Common Stock (20,000 underlying) - Disposition to Issuer
Stock Options (right to buy)
2013-03-01−10,653→ 0 totalExercise: $9.95Exp: 2019-06-18→ Common Stock (10,653 underlying) - Disposition to Issuer
Stock Options (right to buy)
2013-03-01−8,538→ 0 totalExercise: $12.66Exp: 2020-06-17→ Common Stock (8,538 underlying) - Exercise/Conversion
Common Stock
2013-03-01$5.80/sh+18,736$108,669→ 19,811 total - Disposition to Issuer
Common Stock
2013-03-01−27,834→ 0 total - Exercise/Conversion
Stock Options (right to buy)
2013-03-01−18,736→ 0 totalExercise: $5.80Exp: 2021-06-14→ Common Stock (18,736 underlying) - Disposition to Issuer
Stock Options (right to buy)
2013-03-01−18,096→ 0 totalExercise: $17.09Exp: 2017-06-21→ Common Stock (18,096 underlying) - Disposition to Issuer
Stock Options (right to buy)
2013-03-01−8,840→ 0 totalExercise: $11.64Exp: 2018-06-19→ Common Stock (8,840 underlying)
Footnotes (7)
- [F1]This transaction represents a withholding of shares to cover the payment of exercise price pursuant to an exercise of non-qualified stock options.
- [F2]Disposed of pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of November 19, 2012, by and among the Company, Wright Medical Group, Inc. ("Wright"), Achilles Merger Subsidiary, Inc. and Achilles Acquisition Subsidiary, LLC in exchange for the following merger consideration per share of the Company's common stock: (a) $1.50 in cash, without interest; (b) 0.2482 of a share of Wright's common stock; and (c) one contingent value right ("CVR") issued by Wright.
- [F3]Option exercised. Pursuant to the Merger Agreement, this stock option was conditionally vested to 100% subject to exercise upon the merger transaction. The reporting person received merger consideration described in footnote (2) above.
- [F4]Option canceled. Pursuant to the Merger Agreement, the reporting person entered into an agreement with the issuer to terminate stock options with an exercise price greater than $13.00.
- [F5]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 4,613 shares of Wright common stock at an exercise price of $22.31 per share.
- [F6]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 5,559 shares of Wright common stock at an exercise price of $19.07 per share.
- [F7]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 4,455 shares of Wright common stock at an exercise price of $24.26 per share.
Issuer
BIOMIMETIC THERAPEUTICS, INC.
CIK 0001138400
Entity typeother
Related Parties
1- filerCIK 0001213215
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 7:48 PM ET
- Size
- 27.3 KB